Detection of ESBL producing nosocomial gram negative bacteria from a tertiary care hospital in Bangladesh

Pakistan Journal of Medical Sciences

Volumn 26, Issue 4, 2010, Pages 887-891

  Haque, Rezwana ^a   Salam, M Abdus ^b  

^a Islami Bank Medical College   (Bangladesh)

^b RAJSHAHI MEDICAL COLLEGE   (Bangladesh)

Author keywords

Antimicrobial susceptibility; ESBLs; Gram negative bacteria; Wound infections

Indexed keywords

EID: 84872279401     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sanders CC, Sanders WE Jr. Beta-lactam resistance in gramnegative bacteria: Global trends and clinical impact. Clin Infect Dis 1992;15:824-883.
2. Moland SE, Black JA, Ourada J, Reisbig MD, Hanson ND, Thomson KS. Occurrence of newer ß-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother 2002;46:3837-3842.
3. Paterson DL, Bonomo RA. Extended-Spectrum ß-Lactamases: A Clinical Update. Clin Microbiol Rev 2005;18(4):657-686.
4. Bush K. New beta-lactamases in gram-negative bacteria: Diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001;32:1085-1089.
5. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006;43:S43-S48.
6. Bradford PA. Extended-spectrum ß-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
7. th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, May 2009: 16-19.
8. Cheesbrough M. District laboratory practice in tropical countries. Vol. ESBL. Cambridgeshire, England. 2000: 175-80.
9. Kader AA, Angamuthu KK, Kamath KA, Zaman MN. Modified double-disc test for detection of extended-spectrum [beta]-lactamases in Escherichia coli and Klebsiella pneumoniae. British J Biomedical Science 2006; 1-5.
10. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement 2006. CLSI document M100-S16 CLSI, Wayne, Pa.
11. Bauer AW, Kirby WMM, Sherris JC, Turek M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 1966;36:493-496.
12. Livermore DM. ß-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-584.
13. Faustine N, Roland J, Stig H, Willy U, Nina L. Extended Spectrum ß-Lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infect Dis 2005;5:86.
14. Shah AA, Hasan F, Ahmed S, Hameed A. Prevalence of Extended Spectrum Beta Lactamases in Nosocomial and outpatients (ambulatory). Pak J Med Sci 2003;19:87-91.
15. Rahman M, Haq JA, Hossain MA, Sultana R, Islam F, Islam S. Prevalence of extended spectrum Beta lactamases-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh. Int J Antimicrobial Agents 2004;24:508-510.
16. Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, Mehta A. Detection of ß-Lactamases in nosocomial gram negative clinical isolates. Indian J Med Microbiol 2004;22:247-250.
17. Beringer AW. Therapeutic challenges associated with Extended spectrum-lactamase producing Eschcerichia. coli and Klebsiella pneumoniae. Pharmacotherapy 2001;21(5):583-592.
18. Thomson KS. Controversies about Extended spectrum and AmpC beta lactamases. Emerging Infectious Diseases 2001;7(2):333-336.
19. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, et al. Risk factors for increasing multidrug resistance among extended spectrum betalactamase producing Escherichia coli and Klebsiella species. Clin Infect Dis 2005;40:1317-1324.